SN301A
SN301A-001
Phase 1 mab active
Quick answer
SN301A for Hepatocellular Carcinoma (HCC) is a Phase 1 program (mab) at Senti Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Senti Biosciences Holdings
- Indication
- Hepatocellular Carcinoma (HCC)
- Phase
- Phase 1
- Modality
- mab
- Status
- active